GlassScriptPhysician profile
Christopher Ned Carver
NPI 1154313385
$4,127.00
in general payments reported to CMS, 2019-2025
14 companies · $2,024 in 2025
The $2,024 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $152 · 2021: $233 · 2022: $545 · 2023: $502 · 2024: $528 · 2025: $2,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,889 · Travel and Lodging: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,889.42 |
| Travel and Lodging | $1,164.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,639.60 | 2019-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Carl Zeiss Meditec USA, INC. | $1,364.84 | 2025 | |
| Glaukos Corporation | $276.59 | 2022-2025 | Idosetr, Ce-Marked Kxla System |
| Allergan, INC. | $145.49 | 2021-2022 | |
| Lkc Technologies, INC. | $140.38 | 2023-2024 | |
| Ivantis, INC | $115.65 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $110.39 | 2020 | |
| Maculogix, INC. | $102.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.52 | 2022-2023 | |
| Rxsight INC | $56.26 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Bausch & Lomb Americas INC. | $43.82 | 2022-2024 | Envista Mx60 Iol |
| Dompe US, INC. | $29.08 | 2024 | Oxervate |
| Abbvie INC. | $20.32 | 2022 | |
| Sun Pharmaceutical Industries INC. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Carver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.